MyCelx Technologies Corporation Director Dealings & Total Voting Rights
August 23 2024 - 6:05AM
RNS Regulatory News
RNS Number : 6160B
MyCelx Technologies Corporation
23 August 2024
23 August 2024
MYCELX Technologies
Corporation
("MYCELX"
or the "Company") (AIM:MYX)
Director
Dealings & Total Voting Rights
MYCELX Technologies Corporation
("MYCELX" or the "Company"), the clean water and clean air
technology company established to transform the environmental
impact of industry, announces, further to the Placing and
Subscription this morning, the following participation by Directors
of the Company.
|
Director
|
Shares held prior to
Admission
|
New Shares
Purchased
|
Shares held post
Admission
|
Percentage of Enlarged Issued
Share Capital
|
|
Thomas Lamb
|
325,175
|
48,836
|
374,011
|
1.54%
|
|
Connie Mixon1
|
2,803,944
|
100,632
|
2,931,576
|
12.06%
|
|
Andre Schnabl
|
118,011
|
48,836
|
166,847
|
0.69%
|
1 Mrs. Mixon's shareholding includes 229,008 shares in the
Company held by her spouse.
Total Voting Rights
In conformity with the FCA's
Disclosure Guidance and Transparency Rules (the "Rules") provision
5.6.1, the Company would like to notify the market that following
Admission on 4 September 2024 its issued share capital will consist
of 24,315,271 Common Shares of US$0.025 each.
Shareholders should use 24,315,271
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the Company under the
Rules.
Terms and definitions used in this announcement shall have the
same meaning as ascribed to them in the Proposed Placing and
Subscription Announcement released at 7:00 a.m. on 23 August 2024,
unless the context requires otherwise.
For
further information please contact:
|
MYCELX Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
|
Tel: +1 888 306 6843
|
|
Canaccord Genuity Limited (Nominated Adviser and Sole
Broker)
Henry Fitzgerald-O'Connor
Charlie Hammond
|
Tel: +44 20 7523 8000
|
|
Celicourt Communications (Financial PR)
Mark Antelme
Jimmy Lea
Charlie Denley-Myerson
|
Tel: +44 20 7770 6424
|
Notifications of transactions of persons discharging
managerial responsibility or connected persons
|
1
|
Details of the person discharging managerial responsibilities
/ person closely associated
|
|
a)
|
Name
|
1. Thomas
Lamb
2. Connie
Mixon
3. Andre
Schnabl
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
1. Non-Executive
Chairman
2. Chief Executive
Officer
3. Non-Executive
Director
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Mycelx Technologies
Corporation
|
|
b)
|
LEI
|
213800UJZINIK2VD1G48
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Common shares of US$0.025
US62847T2024
|
|
b)
|
Nature of the transaction
|
Purchase of Common Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
1. 51.5 pence
2. 51.5 pence
3. 51.5 pence
|
1. 48,836
2. 100,632
3. 48,836
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A
N/A
|
|
e)
|
Date of the transaction
|
23 August 2024
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
DSHGZGZRGFZGDZM
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Mycelx Technologies (LSE:MYX)
Historical Stock Chart
From Nov 2023 to Nov 2024
